StonvexLoading…
StonvexStonvexStonvexCore line items from ZLAB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $95.56M | $457.18M | $330.10M | $214.74M |
Operating Income | $-69.39M | $-229.43M | $-160.03M | $-111.21M |
Net Income | $-51.02M | $-175.54M | $-125.13M | $-40.73M |
EPS (Diluted) | $-0.05 | $-0.16 | $-0.11 | $-0.08 |
Total Assets | $1.10B | $1.17B | $1.16B | $1.16B |
Total Liabilities | $433.76M | $456.88M | $399.00M | $372.37M |
Cash & Equivalents | $651.32M | $679.57M | $717.15M | $732.16M |
Free Cash Flow OCF − CapEx | $-13.11M | $-158.89M | $-132.19M | $-97.14M |
Shares Outstanding | 1.11B | 1.11B | 1.11B | 1.10B |